Your browser doesn't support javascript.
loading
Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513.
Coulter, Don W; McGuire, Timothy R; Sharp, John G; McIntyre, Erin M; Dong, Yuxiang; Wang, Xiaofang; Gray, Shawn; Alexander, Gracey R; Chatuverdi, Nagendra K; Joshi, Shantaram S; Chen, Xiaoyu; Vennerstrom, Jonathan L.
Afiliación
  • Coulter DW; College of Medicine, Division of Pediatrics, University of Nebraska Medical Center, Omaha, NE, USA.
  • McGuire TR; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA. trmcguir@unmc.edu.
  • Sharp JG; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, USA.
  • McIntyre EM; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
  • Dong Y; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
  • Wang X; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
  • Gray S; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
  • Alexander GR; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
  • Chatuverdi NK; College of Medicine, Division of Pediatrics, University of Nebraska Medical Center, Omaha, NE, USA.
  • Joshi SS; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, USA.
  • Chen X; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
  • Vennerstrom JL; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
BMC Cancer ; 16(1): 867, 2016 11 08.
Article en En | MEDLINE | ID: mdl-27821095

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Compuestos Heterocíclicos / Antimaláricos / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Compuestos Heterocíclicos / Antimaláricos / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos